These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3098161)

  • 1. [Treatment of an infection due to the intraperitoneal inoculation of mice with Pseudomonas aeruginosa with tobramycin and hyperimmune Pseudomonas aeruginosa plasma used per se and in combination].
    Minukhin VV; Tsyganenko AIa
    Antibiot Med Biotekhnol; 1986 Oct; 31(10):778-81. PubMed ID: 3098161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental basis for the combined use of tobramycin and immune preparations for treating acute Pseudomonas aeruginosa infections].
    Minukhin VV; Tsyganenko VIa
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Aug; (8):42-5. PubMed ID: 3094301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dynamics of the contamination of mice during the treatment of burn sepsis due to Pseudomonas aeruginosa using tobramycin alone or combined with active and passive immunization].
    Minukhin VV; Tsyganenko AIa
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Sep; (9):90-2. PubMed ID: 3098009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of tobramycin and immunologic preparations in experimental Pseudomonas infection].
    Minukhin VV; Tsyganenko AIa
    Antibiot Khimioter; 1989 Apr; 34(4):282-6. PubMed ID: 2502083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Morphological study of the organs and tissues of mice infected after a burn with a Pseudomonas aeruginosa strain and treated with a Pseudomonas aeruginosa polyvalent corpuscular vaccine and tobramycin].
    Moroz AF; Kharitonova AM; Chanturiia TsK
    Antibiotiki; 1983 May; 28(5):341-5. PubMed ID: 6410985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of a polyvalent corpuscular Pseudomonas aeruginosa vaccine, antibiotics and their combinations in experimental chronic Pseudomonas aeruginosa infection].
    Vetkova LG; Antsiferova NG; Radkevich SA; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Mar; (3):51-6. PubMed ID: 3922187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive immune therapy for experimental Pseudomonas aeruginosa pneumonia in the neutropenic host.
    Pennington JE; Small GJ
    J Infect Dis; 1987 May; 155(5):973-8. PubMed ID: 3104484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Action of gentamicin, tobramycin and their combinations with prodigiozan in an experimental infection caused by Pseudomonas aeruginosa].
    Shcherbakova EG; Medvedeva MM; Rastunova GA; Sobolev VR
    Antibiotiki; 1975; 20(12):1112-5. PubMed ID: 817650
    [No Abstract]   [Full Text] [Related]  

  • 9. Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model.
    Christensen LD; van Gennip M; Jakobsen TH; Alhede M; Hougen HP; Høiby N; Bjarnsholt T; Givskov M
    J Antimicrob Chemother; 2012 May; 67(5):1198-206. PubMed ID: 22302561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive immunization against Pseudomonas aeruginosa recombinant PilA in a murine burn wound model.
    Mousavi M; Behrouz B; Irajian G; Mahdavi M; Korpi F; Motamedifar M
    Microb Pathog; 2016 Dec; 101():83-88. PubMed ID: 27836762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigations on the efficacy of monovalent Pseudomonas aeruginosa vaccine for oral administration in Pseudomonas aeruginosa experimental infection.
    Meitert E; Sima F; Savulian C; Petrovici M; Chersulick E; Costache G
    Arch Roum Pathol Exp Microbiol; 1989; 48(3):237-51. PubMed ID: 2519634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody activity against Pseudomonas aeruginosa in immune globulins prepared for intravenous use in humans.
    Pollack M
    J Infect Dis; 1983 Jun; 147(6):1090-8. PubMed ID: 6406615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of hyperimmune anti-Pseudomonas plasma in the treatment of infectious complications].
    Grishina IA; Terekhova RP; Marchuk AI; Elagina LV; Ostrovskaia EV; Nezhlukto AIa
    Khirurgiia (Mosk); 1990 Nov; (11):121-3. PubMed ID: 2127294
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of properties of Pseudomonas aeruginosa recombinant outer membrane protein F (OprF)].
    Zlygostev SA; Gataullin AG; Kaloshin AA; Mikhaĭlova NA; Zverev VV
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (7):43-7. PubMed ID: 17297879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent experience with Pseudomonas aeruginosa immune globulin for the treatment of experimental pneumonia.
    Pennington JE
    J Hosp Infect; 1988 Aug; 12 Suppl D():55-60. PubMed ID: 2902130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the specific activity of hyperimmune anti-Pseudomonas aeruginosa human plasma in an experiment].
    Podgornaia LG; Shinkarenko AA; Krokhina MA; Dziuban NF; D'iachenko VF
    Patol Fiziol Eksp Ter; 1987; (2):70-2. PubMed ID: 3112715
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunoprophylaxis and immunotherapy of experimental Pseudomonas aeruginosa sepsis].
    Grishina IA; Terekhova RP; Marchuk AI
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Apr; (4):14-7. PubMed ID: 3087118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pseudomonas aeruginosa immunoglobulin in experimental pneumonia].
    Pennington JE; Pier GB
    Infection; 1987; 15(1):56-9. PubMed ID: 3106230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental study of antibacterial activity, therapeutic effectiveness and toxic properties of the combination of tobramycin and carbenicillin].
    Vinogradova IV; Filippos'iants ST; Shevniuk LA
    Antibiot Khimioter; 1989 May; 34(5):382-6. PubMed ID: 2500902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of rifampin to ticarcillin-tobramycin combination for the treatment of Pseudomonas aeruginosa infections: assessment in a neutropenic mouse model.
    Zuravleff JJ; Chervenick P; Yu VL; Muder RR; Diven WF
    J Lab Clin Med; 1984 Jun; 103(6):878-85. PubMed ID: 6427375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.